%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Lu, I. J.
%A Silhol, R.
%A d'Elbée, M.
%A Boily, M. C.
%A Soni, N.
%A Ky-Zerbo, O.
%A Vautier, A.
%A Fosto, A. S.
%A Badiane, K.
%A Traoré, M.
%A Terris-Prestholt, F.
%A Larmarange, Joseph
%A Maheu-Giroux, M.
%A Atlas Team
%T Cost-effectiveness analysis of community-led HIV self-testing among key populations in Côte d'Ivoire, Mali, and Senegal
%D 2024
%L fdi:010091133
%G ENG
%J Journal of the International Aids Society
%K community-led delivery ; cost function ; cost-effectiveness ; HIV testing ; services ; HIV-self testing ; key population
%K COTE D'IVOIRE ; MALI ; SENEGAL
%M ISI:001273015400001
%N 7
%P e26334 [12 ]
%R 10.1002/jia2.26334
%U https://www.documentation.ird.fr/hor/fdi:010091133
%> https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2024-09/010091133.pdf
%V 27
%W Horizon (IRD)
%X IntroductionHIV self-testing (HIVST) is a promising strategy to improve diagnosis coverage among key populations (KP). The ATLAS (Auto Test VIH, Libre d'Acc & eacute;der & agrave; la connaissance de son Statut) programme implemented HIVST in three West African countries, distributing over 380,000 kits up between 2019 and 2021, focussing on community-led distribution by KP to their peers and subsequent secondary distribution to their partners and clients. We aim to evaluate the cost-effectiveness of community-led HIVST in C & ocirc;te d'Ivoire, Mali and Senegal.MethodsAn HIV transmission dynamics model was adapted and calibrated to country-specific epidemiological data and used to predict the impact of HIVST. We considered the distribution of HIVST among two KP-female sex workers (FSW), and men who have sex with men (MSM)-and their sexual partners and clients. We compared the cost-effectiveness of two scenarios against a counterfactual without HIVST over a 20-year horizon (2019-2039). The ATLAS-only scenario mimicked the 2-year implemented ATLAS programme, whereas the ATLAS-scale-up scenario achieved 95% coverage of HIVST distribution among FSW and MSM by 2025 onwards. The primary outcome is the number of disability-adjusted life-years (DALY) averted. Scenarios were compared using incremental cost-effectiveness ratios (ICERs). Costing was performed using a healthcare provider's perspective. Costs were discounted at 4%, converted to $USD 2022 and estimated using a cost-function to accommodate economies of scale.ResultsThe ATLAS-only scenario was highly cost-effective over 20 years, even at low willingness-to-pay thresholds. The median ICERs were $126 ($88-$210) per DALY averted in C & ocirc;te d'Ivoire, $92 ($88-$210) in Mali and 27$ ($88-$210) in Senegal. Scaling-up the ATLAS programme would also be cost-effective, and substantial epidemiological impacts would be achieved. The ICERs for the scale-up scenario were $199 ($122-$338) per DALY averted in C & ocirc;te d'Ivoire, $224 ($118-$415) in Mali and $61 ($18-$128) in Senegal.ConclusionsBoth the implemented and the potential scale-up of community-led HIVST programmes in West Africa, where KP are important to overall transmission dynamics, have the potential to be highly cost-effective, as compared to a scenario without HIVST. These findings support the scale-up of community-led HIVST to reach populations that otherwise may not access conventional testing services.
%$ 056 ; 052